[Himax Pre-Announces Key Financial Results for Third Quarter 2018 Revenue, Gross Margin and EPS All Outperform Guidance t h TAINAN, Taiwan, Oct. 05, 2018 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers ]
[Himax Pre-Announces Key Financial Results for Third Quarter 2018 Revenue, Gross Margin and EPS All Outperform Guidance t h TAINAN, Taiwan, Oct. 05, 2018 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers ]
[Payment of Filing Fee (Check the appropriate box): ý No fee required o Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11 (1) Title of each class of securities to which transaction applies: (2) Aggregate number of securities to which transaction applies: (3) (4) Proposed maximum ag]
[Payment of Filing Fee (Check the appropriate box): ý No fee required o Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11 (1) Title of each class of securities to which transaction applies: (2) Aggregate number of securities to which transaction applies: (3) (4) Proposed maximum ag]
[Recent Developments of The9 Limited On August 30, 2018, the Company signed a definitive agreement with Leading Choice Holding Limited, a company incorporated in Hong Kong (Leading Choice), and the shareholder of Leading Choice for the issuance and sale of 21,000,000 ordinary shares of the Company ]
[Recent Developments of The9 Limited On August 30, 2018, the Company signed a definitive agreement with Leading Choice Holding Limited, a company incorporated in Hong Kong (Leading Choice), and the shareholder of Leading Choice for the issuance and sale of 21,000,000 ordinary shares of the Company ]
[As required by NYSE rules, no later than October 11, 2018, the Company will notify the NYSE of its intent to cure the share price deficiency and to return to compliance with this continued listing standard. Under NYSE rules, the Company has six months (subject to possible extension) to regain compli]
[As required by NYSE rules, no later than October 11, 2018, the Company will notify the NYSE of its intent to cure the share price deficiency and to return to compliance with this continued listing standard. Under NYSE rules, the Company has six months (subject to possible extension) to regain compli]
